K L Radenbach. Show Affiliations »
Abstract
Mesh: See more » Antitubercular Agents/adverse effectsAntitubercular Agents/therapeutic useDrug CombinationsEthambutol/therapeutic useHumansIsoniazid/therapeutic useIsonicotinic Acids/therapeutic useMicrobial Sensitivity TestsPrognosisProspective StudiesRifampin/therapeutic useStreptomycin/therapeutic useTuberculosis, Pulmonary/diagnosisTuberculosis, Pulmonary/drug therapy
Substances: See more » Antitubercular AgentsDrug CombinationsIsonicotinic AcidsEthambutolIsoniazidRifampinStreptomycin
Year: 1973 PMID: 4573242
Source DB: PubMed Journal: Internist (Berl) ISSN: 0020-9554 Impact factor: 0.743